Recent developments in understanding the role of the gut microbiota in brain health and disease

Annals of the New York Academy of Sciences

Volumn 1420, Issue 1, 2018, Pages 5-25

  Sherwin, Eoin ^a   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

aging; behavior; brain; diet; microbiota; neurodegeneration

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; PREBIOTIC AGENT; PROBIOTIC AGENT;

AGING; ALCOHOLISM; ALZHEIMER DISEASE; AUTISM; BRAIN DISEASE; BRAIN FUNCTION; BRAIN INJURY; CANNABIS ADDICTION; CEREBROVASCULAR ACCIDENT; COCAINE DEPENDENCE; DEPRESSION; DIET SUPPLEMENTATION; HEALTH STATUS; HUMAN; INTESTINE FLORA; MENTAL DISEASE; MICROFLORA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROLOGY; NONHUMAN; PARKINSON DISEASE; PSYCHIATRY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOCIAL BEHAVIOR; BRAIN; DEGENERATIVE DISEASE; DIET THERAPY; DYSBIOSIS; PATHOLOGY; PHYSIOLOGY;

AGING; BRAIN; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; NEURODEGENERATIVE DISEASES; NEURODEVELOPMENTAL DISORDERS; PREBIOTICS; PROBIOTICS;

EID: 85048193971     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13416     Document Type: Review

References (153)

1. Mackowiak, P.A. 2013. Recycling Metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front. Public Health 1: 52.
2. Phillips, J.G.P. 1910. The treatment of melancholia by the lactic acid Bacillus. Br. J. Psychiatry 56: 422–431.
3. Bested, A.C., A.C. Logan & E.M. Selhub. 2013. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II—contemporary contextual research. Gut Pathog. 5: 3.
4. Sherwin, E., K.V. Sandhu, T.G. Dinan & J.F. Cryan. 2016. May the force be with you: the light and dark sides of the microbiota–gut–brain axis in neuropsychiatry. CNS Drugs 30: 1019–1041.
5. Kelly, J.R., P.J. Kennedy, J.F. Cryan, T.G. Dinan, et al. 2015. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric. Front. Cell. Neurosci. 9: 392.
6. Forsythe, P. & W.A. Kunze. 2013. Voices from within: gut microbes and the CNS. Cell. Mol. Life Sci. 70: 55–69.
7. Sampson, T.R. & S.K. Mazmanian. 2015. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17: 565–576.
8. Sarkar, A., S.M. Lehto, S. Harty, et al. 2016. Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci. 39: 763–781
9. Bienenstock, J., W. Kunze & P. Forsythe. 2015. Microbiota and the gut–brain axis. Nutr. Rev. 73: 28–31.
10. Foster, J.A., M. Lyte, E. Meyer & J.F. Cryan. 2016. Gut microbiota and brain function: an evolving field in neuroscience. Int. J. Neuropsychopharmacol. 19: 1–7.
11. Mayer, X.E.A., R. Knight, S.K. Mazmanian, et al. 2014. Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 34: 15490–15496.
12. Mayer, E.A., K. Tillisch & A. Gupta. 2015. Gut/brain axis and the microbiota. J. Clin. Invest. 125: 49–53.
13. Labus, J.S., E.B. Hollister, J. Jacobs, et al. 2017. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome 5: 1–17.
14. Sherwin, E., K. Rea, T.G. Dinan & J.F. Cryan. 2016. A gut (microbiome) feeling about the brain. Curr. Opin. Gastroenterol. 32: 96–102.
15. Dinan, T.G. & J.F. Cryan. 2015. The impact of gut microbiota on brain and behaviour. Curr. Opin. Clin. Nutr. Metab. Care 18: 552–558.
16. Dinan, T.G., R.M. Stilling, C. Stanton & J.F. Cryan. 2015. Collective unconscious: how gut microbes shape human behavior. J. Psychiatr. Res. 63: 1–9.
17. O'Mahony, S.M., G. Clarke, Y.E. Borre, et al. 2015. Serotonin, tryptophan metabolism and the brain–gut–microbiome axis. Behav. Brain Res. 277: 32–48.
18. Burnet, P.W.J. & P.J. Cowen. 2013. Psychobiotics highlight the pathways to happiness. Biol. Psychiatry 74: 708–709.
19. Moos, W.H., D.V. Faller, D.N. Harpp, et al. 2016. Microbiota and neurological disorders: a gut feeling. Biores. Open Access 5: 137–145.
20. Severance, E.G., E. Prandovszky, J. Castiglione & R.H. Yolken. 2015. Gastroenterology issues in schizophrenia: why the gut matters. Curr. Psychiatry Rep. 17: 27.
21. O'Toole, P.W. & I.B. Jeffery. 2015. Gut microbiota and aging. Science 350: 1214–1216.
22. Kong, F., Y. Hua, B. Zeng, et al. 2016. Gut microbiota signatures of longevity. Curr. Biol. 26: R832–R833.
23. Vaiserman, A.M., A.K. Koliada & F. Marotta. 2017. Gut microbiota: a player in aging and a target for anti-aging intervention. Ageing Res. Rev. 35: 36–45.
24. Prenderville, J.A., P.J. Kennedy, T.G. Dinan & J.F. Cryan. 2015. Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38: 13–25.
25. Scott, K.A., M. Ida, V.L. Peterson, et al. 2017. Revisiting Metchnikoff: age-related alterations in microbiota-gut–brain axis in the mouse. Brain Behav. Immun. https://doi.org/10.1016/j.bbi.2017.02.004.
26. Giannelli, V., V. Di Gregorio, V. Iebba, et al. 2014. Microbiota and the gut–liver axis: bacterial translocation, inflammation and infection in cirrhosis. WorldJ. Gastroenterol. 20: 16795–16810.
27. Conley, M.N., C.P. Wong, K.M. Duyck, et al. 2016. Aging and serum MCP-1 are associated with gut microbiome composition in a murine model. Peer J. 4: e1854.
28. Kim, K.-A., J.-J. Jeong, S.-Y. Yoo & D.-H. Kim. 2016. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice. BMC Microbiol. 16: 9.
29. Jeong, J.-J., K.A. Kim, Y.-J. Hwang, et al. 2016. Anti-inflammaging effects of Lactobacillus brevis OW38 in aged mice. Benef. Microbes 7: 1–12.
30. Cho, S.-Y., J. Kim, J.H. Lee, et al. 2016. Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice. Sci. Rep. 6: 39026.
31. Poirier, A.-A., B. Aubé, M. Côté, et al. 2016. Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments. Parkinsons Dis. 2016: 6762528.
32. Felice, V.D., E.M. Quigley, A.M. Sullivan, et al. 2016. Microbiota–gut–brain signalling in Parkinson's disease: implications for non-motor symptoms. Parkinsonism Relat. Disord. 27: 1–8.
33. Forsyth, C.B., K.M. Shannon, J.H. Kordower, et al. 2011. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 6: e28032.
34. Hilton, D., M. Stephens, L. Kirk, et al. 2014. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 127: 235–241.
35. Holmqvist, S., O. Chutna, L. Bousset, et al. 2014. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128: 805–820.
36. Scheperjans, F., V. Aho, P.A.B. Pereira, et al. 2015. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30: 350–358.
37. Bedarf, J.R., F. Hildebrand, L.P. Coelho, et al. 2017. Functional implications of microbial and viral gut metagenome changes in early stage l-DOPA-naïve Parkinson's disease patients. Genome Med. 9: 1–13.
38. Keshavarzian, A., S.J. Green, P.A. Engen, et al. 2015. Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30: 1351–1360.
39. Hill-Burns, E.M., J.W. Debelius, J.T. Morton, et al. 2017. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32: 739–749.
40. Unger, M.M., J. Spiegel, K.-U. Dillmann, et al. 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat. Disord. 32: 66–72.
41. Huuskonen, J., T. Suuronen, T. Nuutinen, et al. 2004. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br. J. Pharmacol. 141: 874–880.
42. Fasano, A., F. Bove, M. Gabrielli, et al. 2013. The role of small intestinal bacterial overgrowth in Parkinson's disease. Mov. Disord. 28: 1241–1249.
43. Çamcı, G. & S. Oğuz. 2016. Association between Parkinson's disease and Helicobacter pylori. J. Clin. Neurol. 12: 147–150.
44. Cassani, E., M. Barichella, R. Cancello, et al. 2015. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease. Parkinsonism Relat. Disord. 21: 389–393.
45. Dobbs, R.J., S.M. Dobbs, C. Weller, et al. 2008. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 13: 309–322.
46. Hashim, H., S. Azmin, H. Razlan, et al. 2014. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. PLoS One 9: e112330.
47. Sampson, T.R., J.W. Debelius, T. Thron, et al. 2016. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167: 1469–1480. e12.
48. Erny, D., A.L. Hrabě de Angelis, D. Jaitin, et al. 2015. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18: 965–977.
49. Cattaneo, A., N. Cattane, S. Galluzzi, et al. 2017. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49: 60–68.
50. Zhan, X., B. Stamova, L.W. Jin, et al. 2016. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87: 2324–2332.
51. Friedland, R.P. 2015. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J. Alzheimers Dis. 45: 349–362.
52. Harach, T., N. Marungruang, N. Duthilleul, et al. 2017. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 7: 41802.
53. Minter, M.R., C. Zhang, V. Leone, et al. 2016. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci. Rep. 6: 30028.
54. Brandscheid, C., F. Schuck, S. Reinhardt, et al. 2017. Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer's mouse model. J. Alzheimers Dis. 56: 775–788.
55. Wang, D., L. Ho, J. Faith, et al. 2015. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease beta-amyloid oligomerization. Mol. Nutr. Food Res. 59: 1025–1040.
56. Distrutti, E., J.-A. O'Reilly, C. McDonald, et al. 2014. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One 9: e106503.
57. Buscarinu, M.C., B. Cerasoli, V. Annibali, et al. 2017. Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: a pilot study. Mult. Scler. 23: 442–446.
58. Escribano, B.M., F.J. Medina-fernández, M. Aguilar-luque & E. Agüera. 2016. Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model. Neurotherapeutics 14: 199–211.
59. Miyake, S., S. Kim, W. Suda & K. Oshima. 2015. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One 10: e0137429.
60. Hoban, A.E., R.M. Stilling, F.J. Ryan, et al. 2016. Regulation of prefrontal cortex myelination by the microbiota. Transl. Psychiatry 6: e774.
61. Gacias, M., S. Gaspari, P.M.G. Santos, et al. 2016. Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior. Elife 5: 1–27.
62. Kyung, Y., J.S. Menezes, Y. Umesaki & S.K. Mazmanian. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 108: 4615–4622.
63. Miller, P.G., M.B. Bonn, C.L. Franklin, et al. 2017. TNFR2 deficiency acts in concert with gut microbiota to precipitate spontaneous sex-biased central nervous system demyelinating autoimmune disease. J. Immunol. 195: 4668–4684.
64. Stanisavljevic, S., J. Lukic, S. Sokivic, et al. 2016. Correlation of gut microbiota composition with resistance to experimental autoimmune encephalomyelitis in rats. Front. Microbiol. 7: 1–12.
65. Yin, J., S.-X. Liao, Y. He, S. Wang, et al. 2015. Dysbiosis of gut microbiota with reduced trimethylamine-n-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J. Am. Heart Assoc. 4: 1–13.
66. Yamashiro, K., R. Tanaka, T. Urabe, et al. 2017. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One 12: e0171521.
67. Winek, K., O. Engel, P. Koduah, et al. 2016. Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 47: 1354–1363.
68. Singh, V., S. Roth, G. Llovera, et al. 2016. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci. 36: 7428–7440.
69. Stanley, D., L.J. Mason, K.E. Mackin, et al. 2016. Translocation and dissemination of commensal bacteria in post-stroke infection. Nat. Med. 22: 1277–1284.
70. Risk, T., W. Zhu, J.C. Gregory, et al. 2016. Gut microbial metabolite TMAO enhances platelet article gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165: 111–124.
71. Wang, Z., A.B. Roberts, J.A. Buffa, et al. 2015. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of article non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163: 1585–1595.
72. Benakis, C., D. Brea, S. Caballero, et al. 2016. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat. Med. 22: 516–523.
73. Sadler, R., V. Singh, C. Benakis, et al. 2017. Microbiota differences between commercial breeders impacts the post-stroke immune response. Brain Behav. Immun. https://doi.org/10.1016/j.bbi.2017.03.011.
74. Houlden, A., M. Goldrick, D. Brough, et al. 2016. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav. Immun. 57: 10–20.
75. Jentsch, H.F.R., D. März & M. Krüger. 2013. The effects of stress hormones on growth of selected periodontitis related bacteria. Anaerobe 24: 49–54.
76. Kigerl, K.A., J.C.E. Hall, L. Wang, et al. 2016. Gut dysbiosis impairs recovery after spinal cord injury. J. Exp. Med. 213: 2603–2620.
77. Sun, J., F. Wang, Z. Ling, et al. 2016. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Res. 1642: 180–188.
78. Zhou, L. & J.A. Foster. 2015. Psychobiotics and the gut–brain axis: in the pursuit of happiness. Neuropsychiatr. Dis. Treat. 11: 715–723.
79. Yu, M., H. Jia, C. Zhou, et al. 2017. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics. J. Pharm. Biomed. Anal. 138: 231–239.
80. Kelly, J.R., Y. Borre, C. O’ Brien, et al. 2016. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr Res. 82: 109–118.
81. Zheng, P., B. Zeng, C. Zhou, et al. 2016. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol. Psychiatry 21:786–796.
82. De Palma, G., M.D.J. Lynch, J. Lu, et al. 2017. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci. Transl. Med. 6397: 1–15.
83. Burokas, A., S. Arboleya, D. Rachel, et al. 2017. Targeting the microbiota–gut–brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol. Psychiatry. https://doi.org/10.1016/j.biopsych.2016.12.031.
84. Savignac, H.M., Y. Couch, M. Stratford, et al. 2016. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1 levels in male mice. Brain Behav. Immun. 52: 120–131.
85. Tarr, A.J., J.D. Galley, S.E. Fisher, et al. 2015. The prebiotics 3′sialyllactose and 6′sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: evidence for effects on the gut–brain axis. Brain Behav. Immun. 50: 166–177.
86. Schmidt, K., P.J. Cowen, C.J. Harmer, et al. 2015. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl.) 232: 1793–1801.
87. Bharwani, A., M.F. Mian, M.G. Surette, et al. 2017. Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med. 15: 7.
88. Bravo, J.A., P. Forsythe, M.V. Chew, et al. 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 108: 16050–16055.
89. Kelly, J.R., A.P. Allen, A. Temko, et al. 2017. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav. Immun. 61: 50–59.
90. Allen, A.P., W. Hutch, Y.E. Borre, et al. 2016. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl. Psychiatry 6: e939.
91. Tillisch, K., J. Labus, L. Kilpatrick, et al. 2013. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144: 1394–1401, 1401.e1-4.
92. Pinto-sanchez, M.I., G.B. Hall, K. Ghajar, et al. 2017. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology https://doi.org/10.1053/j.gastro.2017.05.003.
93. Xu, M., H. Cao, W. Wang, et al. 2015. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J. Gastroenterol. 21: 102–111.
94. Evrensel, A. & M.E. Ceylan. 2016. Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin. Psychopharmacol. Neurosci. 14: 231–237.
95. Holzer, P. & A. Farzi. 2014. Neuropeptides and the microbiota–gut–brain axis. Adv. Exp. Med. Biol. 817: 39–71.
96. Holzer, P. 2016. Neuropeptides, microbiota, and behavior. Int. Rev. Neurobiol. 131: 67–89.
97. Buffington, S.A., G.V. Di Prisco, T.A. Auchtung, et al. 2016. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165: 1762–1775.
98. Desbonnet, L., G. Clarke, F. Shanahan, et al. 2014. Microbiota is essential for social development in the mouse. Mol. Psychiatry 19: 146–148.
99. Desbonnet, L., G. Clarke, A. Traplin, et al. 2015. Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav. Immun. 48: 165–173.
100. Arentsen, T., H. Raith, Y. Qian, et al. 2015. Host microbiota modulates development of social preference in mice. Microb. Ecol. Health Dis. 26: 29719.
101. de Theije, C.G.M., H. Wopereis, M. Ramadan, et al. 2014. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav. Immun. 37: 197–206.
102. de Theije, C.G., P.J. Koelink, G.A. Korte-Bouws, et al. 2014. Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav. Immun. 37: 240–247.
103. Hsiao, E.Y., S.W. McBride, S. Hsien, et al. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155: 1451–1463.
104. McFarlane, H.G., G.K. Kusek, M. Yang, et al. 2008. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 7: 152–163.
105. Kazdoba, T.M., R.J. Hagerman, D. Zolkowska, et al. 2015. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl.) 233: 309–323.
106. Kratsman, N., D. Getselter & E. Elliott. 2016. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. Neuropharmacology 102: 136–145.
107. Newell, C., M.R. Bomhof, R.A. Reimer, et al. 2016. Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism 7: 37.
108. Kang, D.-W., J.B. Adams, A.C. Gregory, et al. 2017. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5: 10.
109. De La Torre-Ubieta, L., H. Won, J.L. Stein & D.H. Geschwind. 2016. Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22: 345–361.
110. Gilbert, J.A., R. Krajmalnik-Brown, D.L. Porazinska, et al. 2013. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell 155: 1446–1448.
111. Varian, B.J., T. Poutahidis, B.T. DiBenedictis, et al. 2016. Microbial lysate upregulates host oxytocin. Brain Behav. Immun. 61: 36–49.
112. Spanogiannopoulos, P., E.N. Bess, R.N. Carmody & P.J. Turnbaugh. 2016. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14: 273–287.
113. Davey, K.J., P.D. Cotter, O. O'Sullivan, et al. 2013. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl. Psychiatry 3: e309.
114. Llopis, M., A.M. Cassard, L. Wrzosek, et al. 2016. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65: 830–839.
115. Peterson, V.L., N.J. Jury, R. Cabrera-Rubio, et al. 2017. Drunk bugs: chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice. Behav. Brain Res. 323: 172–176.
116. Tsuruya, A., A. Kuwahara, Y. Saito, et al. 2016. Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer. Sci. Rep. 6: 27923.
117. Leclercq, S., S. Matamoros, P.D. Cani, et al. 2014. Intestinal permeability, gut–bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U.S.A. 111: E4485–E4493.
118. Sokol, H., B. Pigneur, L. Watterlot, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105: 16731–16736.
119. Devkota, S., Y. Wang, M.W. Musch, et al. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10–/– mice. Nature 487: 104–108.
120. Kiraly, D.D., D.M. Walker, E.S. Calipari, et al. 2016. Alterations of the host microbiome affect behavioral responses to cocaine. Sci. Rep. 6: 35455.
121. Cluny, N.L., C.M. Keenan, R.A. Reimer, et al. 2015. Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with δ9-tetrahydrocannabinol. PLoS One 10: e0144270.
122. Plovier, H., A. Everard, C. Druart, et al. 2017. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23: 107–113.
123. Sonnenburg, E.D., S.A. Smits, M. Tikhonov, et al. 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529: 212–215.
124. Turroni, S., J. Fiori, S. Rampelli, et al. 2016. Fecal metabolome of the Hadza hunter-gatherers: a host–microbiome integrative view. Sci. Rep. 6: 32826.
125. Power, S.E., I.B. Jeffery, R.P. Ross, et al. 2014. Food and nutrient intake of Irish community-dwelling elderly subjects: who is at nutritional risk? J. Nutr. Health Aging 18: 561–572.
126. Sandhu K.V., E. Sherwin, H. Schellekens, et al. 2016. Feeding the microbiota–gut–brain axis: diet, microbiome and neuropsychiatry. Transl. Res. 179: 223–244.
127. Robertson, R.C., C. Seira Oriach, K. Murphy, et al. 2016. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav. Immun. 59: 21–37
128. Pusceddu, M.M., P. Kelly, N. Ariffin, et al. 2015. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: effects of early life stress. Psychoneuroendocrinology 58: 79–90.
129. Jacka, F.N., A. O'Neil, C. Itsiopoulos, et al. 2016. A randomised, controlled trial of a dietary intervention for adults with major depression (the “SMILES” trial): results. In Proceedings of the 18th Annual Conference of the International Society for Bipolar Disorders held jointly with the 8th Biennial Conference of the International Society For Affective Disorders. 1–13. Amsterdam.
130. Ruskin, D.N., J. Svedova, J.L. Cote, et al. 2013. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One 8: 4–9.
131. Ruskin, D.N., M.I. Murphy, S.L. Slade & S.A. Masino. 2017. Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder. PLos One 12: e0171643.
132. Castro, K., D. Baronio, I.S. Perry, et al. 2016. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid. Nutr. Neurosci. 9: 1–8.
133. Wu, J., C.G.M. de Theije, S.L. da Silva, et al. 2016. Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice. Brain Behav. Immun. 59: 273–287.
134. Ghalichi, F., J. Ghaemmaghami, A. Malek & A. Ostadrahimi. 2016. Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial. World J. Pediatr. 12: 436–442.
135. Scott, K.P., J.-M. Antoine, T. Midtvedt & S. van Hemert. 2015. Manipulating the gut microbiota to maintain health and treat disease. Microb. Ecol. Health Dis. 26: 25877.
136. Arentsen, T., Y. Qian, S. Gkotzis, et al. 2017. The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol. Psychiatry 22: 257–266.
137. D'Mello, C., N. Ronaghan, R. Zaheer, et al. 2015. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J. Neurosci. 35: 10821–10830.
138. Bercik, P., A.J. Park, D. Sinclair, et al. 2011. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterol. Motil. 23: 1132–1139.
139. Poutahidis, T., S.M. Kearney, T. Levkovich, et al. 2013. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 8: e78898.
140. Lyte, M. & J.F. Cryan, Eds. 2014. Microbial Endocrinology: The Microbiota–Gut–Brain Axis in Health and Disease. Springer.
141. Lyte, M. 2016. Microbial endocrinology in the pathogenesis of infectious disease. Microbiol. Spectr. 4.
142. Yano, J.M., K. Yu, G.P. Donaldson, et al. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161: 264–276.
143. Clarke, G., S. Grenham, P. Scully, et al. 2013. The microbiome–gut–brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18: 666–673.
144. Breton, J., N. Tennoune, N. Lucas, et al. 2016. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab. 23: 1–11.
145. Tennoune, N., P. Chan, J. Breton, et al. 2014. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders. Transl. Psychiatry 4: e458.
146. Panaro, B.L., I.R. Tough, M.S. Engelstoft, et al. 2014. The melanocortin-4 receptor is expressed in enteroendocrine l cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. Cell Metab. 20: 1018–1029.
147. Breton, J., R. Legrand, K. Akkermann, et al. 2016. Elevated plasma concentrations of bacterial ClpB protein in patients with eating disorders. Int. J. Eat Disord. 49: 805–808.
148. Mcvey Neufeld, K.A., Y.K. Mao, J. Bienenstock, et al. 2013. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol. Motil. 25: 183–190.
149. Mcvey Neufeld, K.A., A. Perez-Burgos, Y.K. Mao, et al. 2015. The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin. Neurogastroenterol. Motil. 27: 627–636.
150. Luczynski, P., K.A.M.V. Neufeld, C.S. Oriach, et al. 2016. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacol. 19: 1–17.
151. Wang, B., Y.K. Mao, C. Diorio, et al. 2009. Lactobacillus reuteri ingestion and IKCa channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol. Motil. 22: 98–e33.
152. Wu, R.Y., M. Pasyk, B. Wang, et al. 2013. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol. Motil. 25: e205–1.
153. Mao, Y.-K., D.L. Kasper, B. Wang, et al. 2013. Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat. Commun. 4: 1465.